Clinical Trial Update: Cara CDRM (Conduction Disturbance Risk Monitor) 2.0 [NA]

View source ↗

Summary

The clinical trial Cara CDRM 2.0 for Transcatheter Aortic Valve Replacement (NCT05465655) sponsored by Cara Medical Ltd was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Snippet

Sponsor: Cara Medical Ltd | Conditions: Transcatheter Aortic Valve Replacement | NA | Status: TERMINATED